Trail Ridge Investment Advisors LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, Holdings Channel reports. The fund bought 5,426 shares of the company’s stock, valued at approximately $697,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Frazier Financial Advisors LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at about $25,000. Rakuten Securities Inc. acquired a new stake in Merck KGaA in the 2nd quarter valued at approximately $27,000. Solstein Capital LLC acquired a new stake in Merck KGaA in the 2nd quarter valued at approximately $33,000. Burk Holdings LLC bought a new position in Merck KGaA in the 2nd quarter worth approximately $39,000. Finally, Bard Associates Inc. bought a new position in Merck KGaA in the 2nd quarter worth approximately $60,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.1%
Shares of MKGAF stock opened at $163.45 on Tuesday. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a market cap of $21.12 billion, a PE ratio of 24.95 and a beta of 0.96. The stock has a 50 day moving average of $162.78 and a 200-day moving average of $148.59.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
